Abstract-In the pathogenesis of cardiovascular events, interaction between risk factors has seldom been identified.However, endothelial dysfunction on the one hand and type 2 diabetes mellitus, impaired glucose metabolism (IGM), and insulin resistance on the other may act synergistically (ie, interact) in the development of cardiovascular disease. We therefore investigated the interaction between endothelial dysfunction and type 2 diabetes mellitus, IGM, and insulin resistance with regard to risk of cardiovascular events. In a prospective population-based cohort (n=445; 69 years; 55% women; 23% type 2 diabetes mellitus, 28% IGM [by design]), endothelial dysfunction (brachial artery flow-mediated dilatation), glucose tolerance (oral glucose tolerance test), and insulin sensitivity (homeostasis model assessment for insulin resistance [HOMA2-IR]) were determined. After a median follow-up of 7.6 years, 106 participants had had a cardiovascular event. After adjustments, 1 SD less flow-mediated dilatation was associated with cardiovascular events in type 2 diabetes mellitus (hazard ratio 1.69 [95% confidence interval, 1.14-2.52]) and IGM ( may amplify the detrimental effects of endothelial dysfunction on atherothrombosis via multiple pathways, including overproduction of reactive oxygen species, low-grade inflammation, and increased procoagulant activity and platelet aggregation. 9 Similar mechanisms may be operative in individuals with impaired glucose metabolism (IGM; ie, impaired fasting glucose and impaired glucose tolerance) or with insulin resistance but with normal glucose tolerance, in whom an increased risk of cardiovascular events is also apparent. 10,11 If the above hypothesis is correct, then the co-occurrence of endothelial dysfunction and DM2 will increase cardiovascular event risk more than expected on the basis of the presence of these processes alone. This phenomenon is called causal interaction or interaction on an additive scale 12,13 and can be formally tested in observational data through the calculation of the relative excess risk due to interaction (RERI).
12To date, 2 previous studies, an earlier report of the Hoorn Study 4 and the Framingham Offspring Study, 5 have evaluated the joint effects of endothelial dysfunction, as determined by plasma biomarkers, and DM2 on incident cardiovascular events. In agreement with the above hypothesis, these studies showed that endothelial dysfunction was most strongly associated with incident cardiovascular events in individuals with DM2 as compared with those without DM2. However, these studies did not evaluate causal interaction (ie, interaction on an additive scale). In addition, these studies did not measure flow-mediated dilatation (FMD), a key functional measure of endothelium-dependent, nitric oxide-mediated dilatation.14 In view of the above, we investigated, in a general elderly population, the association between endothelial dysfunction, as determined by FMD, and incident cardiovascular events, and formally tested, for the first time, whether any...